Skip to main content
UniHealth

Doctor search

Irene Chang, MD

Pediatric Medicine · San Francisco

NPI 1033539671

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
3
1 carrier
Offices
3
Since medical school
12 years
Graduated 2014

Offices

3 locations · UCSF Pediatrics Associates · University of California San Francisco

Looking this up.

Plans that list them

3 plans · 1 carrier

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chang’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

Plans whose provider directory lists this clinician
Imperial Courage Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Dynamic Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Senior Value (HMO C-SNP)Imperial Health Plan of California, Inc.ListedSep 1, 2026

State licence records

1 licence

  • Washington MD.MD.60654898Physician And Surgeon License · since 2016 · expires 2026-06-08
    ExpiredNo board action on this licenceCheck it with the state

We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.

Original Medicare doctor bills

$3,706

Medicare paid this office $3,706 for 15 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)11$1,686$112
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or14$1,222$27

Who their Medicare patients are

15 Original Medicare patients in 2024. Average age 56 · 85 and older 0% · Health risk score 1.86. Above the middle of the specialty; the typical pediatric medicine clinician is at 1.4.

The office billed $24,380, Medicare allowed $5,031 and paid $3,706; for 66 services of 3 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Medicaid work

$20,933 in 2024

Medicaid paid $20,933 for 202 billed services this clinician did in 2024, up to 22 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Long return visit (40+ min)83$14,928
Prolonged outpatient evaluation and management service(s) time with or without direct patient contact beyond the required time of the primary service when the primary service level has been selected using total time, each 15 minutes of total time (List separately in addition to the code of the outpatient Evaluation and Management service)60$5,317
Telehealth transmission, per minute, professional services bill separately59$689
Medicaid work by year
2024202322$20,933
202332219$1,800
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Long return visit (40+ min)13$1,591
Telehealth transmission, per minute, professional services bill separately19$209

Drugs they prescribed that Part D paid

$1,590,399

Pharmacies billed $1,590,399 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 47) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.

0 generic and 40 brand-name prescriptions · $1,590,399 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Dojolvi13$116,129$8,933

Year by year

Part D prescribing by year
202447None0% (0)85%$1,590,399
202323None0% (0)None$139,377
202218None0% (0)78%$42,655

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2022: 1 drug

Part D drugs prescribed in 2022
Cystadane11$42,191$3,836

Money from drug and device companies

$9,587 in 2025

Industry payments by year
202547$9,500$9,587
202411None$38
202111None$30
201911None$38

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
BioMarin PharmaceuticalNone$5,475
4 payments
  • Consulting · 2025-12-31 · $1,369
  • Consulting · 2025-12-31 · $1,369
  • Consulting · 2025-12-31 · $1,369
  • Consulting · 2025-12-31 · $1,369
Chiesi USAElfabrio$4,025
1 payment
  • Paid to speak or teach for Elfabrio · 2025-06-05 · $4,025
StrykerNa$69
1 payment
  • Meals for Na · 2025-08-05 · $69
Avita Medical AmericasPermeaderm$19
1 payment
  • Meals for Permeaderm · 2025-07-29 · $19
See all 7 published payments
Every published payment
BioMarin PharmaceuticalConsulting · 2025-12-31None$1,369
BioMarin PharmaceuticalConsulting · 2025-12-31None$1,369
BioMarin PharmaceuticalConsulting · 2025-12-31None$1,369
BioMarin PharmaceuticalConsulting · 2025-12-31None$1,369
StrykerMeals · 2025-08-05Na$69
Avita Medical AmericasMeals · 2025-07-29Permeaderm$19
Chiesi USAPaid to speak or teach · 2025-06-05Elfabrio$4,025
See earlier years (2024, 2021, 2019)

2024: $38

Payments by company in 2024
BioMarin PharmaceuticalNone$38
1 payment
  • Education · 2024-09-10 · $38

2021: $30

Payments by company in 2021
Ultragenyx PharmaceuticalDojolvi$30
1 payment
  • Education for Dojolvi · 2021-05-17 · $30

2019: $38

Payments by company in 2019
BioMarin PharmaceuticalNone$38
1 payment
  • Education · 2019-09-25 · $38

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
GENZYME CORPORATION · Dfi-Phase 1/2 Dose Esc & Exp Study of Sar444836 (Gene Therapy) in Pts. W/Phenlyketonuria · 2025Their institution$75,659
Ultragenyx Pharmaceutical Inc. · Ux007-Cl401 · 2024Their institution$57,487
Ultragenyx Pharmaceutical Inc. · Ux007-Cl401 · 2025Their institution$40,296
SANOFI US SERVICES INC. · Fabry Disease Registry Protocol · 2025Their institution$8,213
SANOFI US SERVICES INC. · Fabry Disease Registry Protocol · 2024Their institution$7,461
BioMarin Pharmaceutical Inc. · Cerliponase Alfa Observational Study US) · 2022Their institution$7,112
BioMarin Pharmaceutical Inc. · Cerliponase Alfa Observational Study US) · 2021Their institution$5,000
SANOFI US SERVICES INC. · Pompe Disease Registry · 2023Their institution$4,775
BioMarin Pharmaceutical Inc. · Cerliponase Alfa Observational Study (US) · 2024Their institution$4,281
BioMarin Pharmaceutical Inc. · Cerliponase Alfa Observational Study (US) · 2023Their institution$2,590
SANOFI US SERVICES INC. · Dfi-Phase 1/2 Dose Esc & Exp Study of Sar444836 (Gene Therapy) in Pts. W/Phenlyketonuria · 2024This clinician$2,378
SANOFI US SERVICES INC. · Fabry Disease Registry Protocol · 2023Their institution$1,675
SANOFI US SERVICES INC. · Mucopolysaccharidosis I (Mps I) Registry · 2023Their institution$1,550
SANOFI US SERVICES INC. · Gaucher Disease Registry Protocol · 2023Their institution$425
SANOFI US SERVICES INC. · Gaucher Disease Registry Protocol · 2025Their institution$399
SANOFI US SERVICES INC. · Pompe Disease Registry · 2025Their institution$266

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
74.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1033539671
Licence
WA MD60654898Washington MD.MD.60654898: Expired
Group
UCSF Pediatrics Associates · University of California San Francisco
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Medicaid ID
WA 1033539671
Taxonomy
Federal specialty code 207SG0201X (207SG0201X); Federal specialty code 207SG0202X (207SG0202X)
Mailing address
1825 4th St Fl 6, San Francisco, CA, 94143
NPI first listed
2014-04-22
NPI last updated
2024-08-29
NPI record certified
2024-08-29

This is when the NPI record was last certified, not a medical board exam.